We are live on
!
Find out more
Mariner Portfolio holdings
AUM
$85.7B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$37.3B
AUM Growth
-$139M
(-0.37%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
3.39%
Top 10 Holdings %
Top 10 Hldgs %
23.29%
Holding
3,073
New
246
Increased
1,628
Reduced
940
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$74.9M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$64.5M |
| 3 |
Take-Two Interactive
TTWO
|
+$49.4M |
| 4 |
Apple
AAPL
|
+$43.6M |
| 5 |
Tesla
TSLA
|
+$40.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$57.6M |
| 2 |
Ventas
VTR
|
+$43.1M |
| 3 |
Verizon
VZ
|
+$26.2M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$22.5M |
| 5 |
Pfizer
PFE
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 7.23% |
| 3 | Healthcare | 6.88% |
| 4 | Consumer Discretionary | 6.37% |
| 5 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CORR
2826
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $26.3K | ﹤0.01% |
32,920
| – | – |
|
2827
The Oncology Institute
TOI
$498M
| $25.6K | ﹤0.01% |
18,302
+1,391
| +8% | +$1.44K |
|
|
ESPR
2828
DELISTED
Esperion Therapeutics
ESPR
| $25.6K | ﹤0.01% |
26,130
+4,141
| +19% | +$5.99K |
|
2829
Workhorse Group
WKHS
$29.5M
| $25.6K | ﹤0.01% |
21
+6
| +40% | +$15.4K |
|
|
OLPX
2830
DELISTED
Olaplex Holdings
OLPX
| $25.5K | ﹤0.01% |
13,089
+57
| +0.4% | +$172 |
|
2831
SES AI
SES
$186M
| $24.3K | ﹤0.01% |
+10,719
| New | +$26K |
|
2832
ProQR Therapeutics
PRQR
$243M
| $23.8K | ﹤0.01% |
18,334
| – | – |
|
2833
Alpha Tau Medical Warrant
DRTSW
$74.4M
| $23.7K | ﹤0.01% |
93,888
| – | – |
|
|
EGIO
2834
DELISTED
Edgio, Inc. Common Stock
EGIO
| $23.6K | ﹤0.01% |
+692
| New | +$21.7K |
|
2835
Q32 Bio
QTTB
$450M
| $23.2K | ﹤0.01% |
1,102
| – | – |
|
|
DNMR
2836
DELISTED
Danimer Scientific, Inc.
DNMR
| $22.7K | ﹤0.01% |
275
-46
| -14% | -$4.17K |
|
2837
Veru
VERU
$36.1M
| $22.2K | ﹤0.01% |
3,089
-1,166
| -27% | -$12.7K |
|
|
NOTE
2838
DELISTED
FiscalNote
NOTE
| $21.2K | ﹤0.01% |
+851
| New | +$29.1K |
|
2839
Galectin Therapeutics
GALT
$229M
| $20.9K | ﹤0.01% |
10,878
+78
| +0.7% | +$128 |
|
|
AMRN
2840
Amarin Corp
AMRN
$284M
| $19.9K | ﹤0.01% |
1,084
+411
| +61% | +$8.91K |
|
2841
Opko Health
OPK
$921M
| $19.2K | ﹤0.01% |
11,979
+1,871
| +19% | +$3.41K |
|
|
TSP
2842
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $19.1K | ﹤0.01% |
12,240
-1,737
| -12% | -$3.04K |
|
2843
Quantum-Si Incorporated
QSI
$168M
| $18.7K | ﹤0.01% |
+11,263
| New | +$27.1K |
|
2844
Gevo
GEVO
$396M
| $17.9K | ﹤0.01% |
15,001
-7,023
| -32% | -$10.4K |
|
2845
Invivyd
IVVD
$180M
| $17.4K | ﹤0.01% |
+10,239
| New | +$16.3K |
|
|
OPTN
2846
DELISTED
OptiNose
OPTN
| $17K | ﹤0.01% |
921
+49
| +6% | +$882 |
|
|
GOEV
2847
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $16.9K | ﹤0.01% |
75
+12
| +19% | +$3.02K |
|
2848
Smartbird Inc
BIRD
$21.7M
| $15.8K | ﹤0.01% |
+713
| New | +$19.2K |
|
|
LILM
2849
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $15K | ﹤0.01% |
21,064
-20
| -0.1% | -$23 |
|
|
NGD
2850
DELISTED
New Gold Inc
NGD
| $13.8K | ﹤0.01% |
15,196
-12,395
| -45% | -$13.2K |
|
Similar funds
Mariner's Q3 2023 Portfolio in Review
As of Q3 2023, Mariner held 3,073 positions worth $37.3B, down 0.37% from $37.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Mariner deployed $1.26B of net new capital in Q3 2023, opening 246 new positions and adding to 1,628 existing holdings. Its largest new stake was First Commonwealth Financial: 2,690,791 shares worth $32.9M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $57.6M trimmed.
- Mariner's largest Q3 2023 buy was First Commonwealth Financial: 2,690,791 shares worth $32.9M.
- Mariner added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $74.9M increase.
- Mariner's biggest Q3 2023 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $57.6M.
- Mariner fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $12M.
- Mariner's ten largest holdings make up 23% of its $37.3B portfolio in Q3 2023.
- Mariner opened 246 new positions and closed 180 in Q3 2023.
- Mariner's portfolio value fell 0.37% quarter-over-quarter to $37.3B.
Based on Mariner's 13F filing for Q3 2023, filed 13 Nov 2023.